These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27576086)

  • 21. Synthesis of novel 19-norvitamin D3 analogs with unnatural triene system.
    Kulesza U; Mouriño A; Plum LA; Deluca HF; Sicinski RR
    J Steroid Biochem Mol Biol; 2013 Jul; 136():23-6. PubMed ID: 23270753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
    Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
    Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
    Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of 19-norcalcitriol analogs with pegylated alkylidene chains at C-2.
    Fabisiak A; Brzeminski P; Berkowska K; Marcinkowska E; Sicinski RR
    J Steroid Biochem Mol Biol; 2019 Jan; 185():251-255. PubMed ID: 30244047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.
    Sato M; Nakamichi Y; Nakamura M; Sato N; Ninomiya T; Muto A; Nakamura H; Ozawa H; Iwasaki Y; Kobayashi E; Shimizu M; DeLuca HF; Takahashi N; Udagawa N
    Bone; 2007 Feb; 40(2):293-304. PubMed ID: 17070129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new approach to 19-nor-A-ring phosphine oxide for the convergent synthesis of 19-nor-calcitriol.
    Sigüeiro R; Otero R; González-Berdullas P; Loureiro J; Mouriño A; Maestro MA
    J Steroid Biochem Mol Biol; 2017 Oct; 173():86-88. PubMed ID: 27592138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position.
    Kobayashi E; Shimazaki M; Miyamoto Y; Masuno H; Yamamoto K; DeLuca HF; Yamada S; Shimizu M
    Bioorg Med Chem; 2007 Feb; 15(3):1475-82. PubMed ID: 17110116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel 2-alkyl-1alpha,25-dihydroxy-19-norvitamin D3: efficient synthesis with Julia olefination, evaluation of biological activity and development of new analyzing system for co-activator recruitment.
    Arai MA; Kittaka A
    Anticancer Res; 2006; 26(4A):2621-31. PubMed ID: 16886672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel superagonist analogs of 2-methylene calcitriol: Design, molecular docking, synthesis and biological evaluation.
    Sibilska-Kaminski IK; Fabisiak A; Brzeminski P; Plum LA; Sicinski RR; DeLuca HF
    Bioorg Chem; 2022 Jan; 118():105416. PubMed ID: 34798456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of the CYP24A1 major metabolite of 2α-[2-(tetrazol-2-yl)ethyl]-1α,25-dihydroxyvitamin D
    Takano M; Yasuda K; Tohyama E; Higuchi E; Sakaki T; Kittaka A
    J Steroid Biochem Mol Biol; 2017 Oct; 173():75-78. PubMed ID: 27923594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New highly calcemic 1 alpha,25-dihydroxy-19-norvitamin D(3) compounds with modified side chain: 26,27-dihomo- and 26,27-dimethylene analogs in 20S-series.
    Sicinski RR; Prahl JM; Smith CM; DeLuca HF
    Steroids; 2002 Mar; 67(3-4):247-56. PubMed ID: 11856548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives.
    Glebocka A; Sicinski RR; Plum LA; Clagett-Dame M; DeLuca HF
    J Med Chem; 2006 May; 49(10):2909-20. PubMed ID: 16686534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methyl substitution of the 25-hydroxy group on 2-methylene-19-nor-1alpha,25-dihydroxyvitamin D3 (2MD) reduces potency but allows bone selectivity.
    Grzywacz P; Plum LA; Sicinski RR; Clagett-Dame M; DeLuca HF
    Arch Biochem Biophys; 2007 Apr; 460(2):274-84. PubMed ID: 17094936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2-Ethyl and 2-ethylidene analogues of 1alpha,25-dihydroxy-19-norvitamin D(3): synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain.
    Sicinski RR; Rotkiewicz P; Kolinski A; Sicinska W; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 2002 Aug; 45(16):3366-80. PubMed ID: 12139448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological activity of D-bishomo-1α,25-dihydroxyvitamin D
    Fabisiak A; Brzeminski P; Sicinski RR; Rochel N; Maj E; Filip-Psurska B; Wietrzyk J; Plum LA; DeLuca HF
    Eur J Med Chem; 2024 May; 271():116403. PubMed ID: 38615411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes.
    Takaku H; Miyamoto Y; Asami S; Shimazaki M; Yamada S; Yamamoto K; Udagawa N; DeLuca HF; Shimizu M
    Bioorg Med Chem; 2008 Feb; 16(4):1796-815. PubMed ID: 18032055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1-desoxy analog of 2MD: synthesis and biological activity of (20S)-25-hydroxy-2-methylene-19-norvitamin D3.
    Sibilska I; Barycka KM; Sicinski RR; Plum LA; Deluca HF
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):51-5. PubMed ID: 20347975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of 6-methyl analog of 1alpha,25-dihydroxyvitamin D3.
    Sokolowska K; Mouriño A; Sicinski RR; Sigüeiro R; Plum LA; DeLuca HF
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):29-33. PubMed ID: 20153829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New 1alpha,25-dihydroxy-19-norvitamin D3 analogs with a frozen A-ring conformation.
    Glebocka A; Sicinski RR; Plum LA; DeLuca HF
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):46-50. PubMed ID: 20214980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.